---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-071145"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2024-08-20T23:59:59+00:00"
generated_at: "2026-05-31T08:24:43.098413+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# ABVC BioPharma updates corporate presentation; no material new details disclosed

## Summary
- Company filed Form 8-K furnishing an updated corporate presentation on August 20, 2024.
- Filing text and exhibit provide no specific financial data, milestones, or strategic changes.
- No guidance, partnerships, product developments, or other substantive updates revealed.

## SEC filing metadata
- accession: 0001213900-24-071145
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2024-08-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390024071145/0001213900-24-071145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390024071145/ea0211916-8k_abvc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-071145
- JSON: https://secwatch.observer/filing/0001213900-24-071145.json
- Plain text: https://secwatch.observer/filing/0001213900-24-071145.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.